Research 01. How NRAS supports research From conducting our own research about the impact of RA on people’s lives to assisting third-party researchers, academics and professionals – we support research in a number of ways. Read more 02. Current research Find out about the research projects we are currently supporting. Read more 03. Get involved in research NRAS is committed to improving a broad range of outcomes for the RA community. In achieving these aims we work on a number of separate but entwined strategies covering issues such as policy reform, the develop of self-management resources, providing support and help to people experiencing health, social and psychological issues related to their RA. Take part 04. Research outcomes It is important that the full loop occurs when it comes to research, its not just taking part it is also finding out the results. Within this section you will find research outcomes. Read more 05. For researchers NRAS is open to supporting a wide variety of institutions and commercial organisations with their research via various means of recruitment, focus groups, promotion of research and production of surveys. Read more What's Happening News, 13 May Update on COVID-19 Vaccine All patients with RA are encouraged to receive a COVID-19 vaccine. This includes people taking Disease Modifying Anti Rhematic Drugs such as methotrexate, sulfasalazine, leflunomide and hydroxychloroquine and/or advanced therapies such as biologics, biosimilars and JAK inhibitors. The only potential exception is for those on rituximab for which it is recommended to have a consultation […] News, 21 Sep Covid Choices survey results 1 in 3 people delay medical care in COVID-19 pandemic. Lack of information drives on-going fear of attending appointments. Patients need clear, consistent information about COVID-19 safety measures before going to hospital and GP appointments, according to a public survey led by the Patient Information Forum (PIF). 21/09/2020 More than 800 people responded to the […] Get all the latest news and events straight to your inbox with our regular email. Don't worry, we won't send you spam! Sign up Search for resources Try searching our resource hub to find the articles, videos, tools and publications most helpful for you. I am… Employer Health Professional Someone with RASelect topic… About NRAS COVID-19 Diagnosis and Monitoring Diet and Exercise Family Planning Healthcare professionals Other Conditions RA Stories Research Self Care Symptoms and Causes Treatment Work and BenefitsSelect resource type… Article Publication Video Clear All Article MoNoPly study Are you living with painful inflammatory arthritis and interested in taking part in a research study? This MoNoPly study aims to understand what aspects of brain function might be contributing to pain symptoms in people with chronic pain. This project is looking for people who: Are aged 18+. Experience pain from inflammatory arthritis (e.g. rheumatoid […] Article FAQs on New Antiviral Treatment Who is eligible for the treatment? The official list of those eligible can be found in appendix 1 of the clinical commissioning policy published on the 24th of December 2021. See the full, published policy here. With regards to rheumatoid arthritis and immune-mediated inflammatory disorders, the following have been identified: IMID treated with rituximab or other […] Article Research Priorities in Psoriatic Arthritis Introduction This process aimed to identify and prioritise the Top 10 research questions or evidence uncertainties for psoriatic arthritis in adults. A Priority Setting Partnership aims to help ensure that those who fund health research know what really matters to people living with psoriatic arthritis, their carers and clinicians. Methods The British Psoriatic Arthritis Consortium […] Article Office Admin Assistant The National Rheumatoid Arthritis Society (NRAS), is the only patient-led organisation in the UK specialising in rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). Due to its targeted focus on RA and JIA, NRAS provides truly expert and wide-ranging services to support, educate and campaign for people living with these complex autoimmune conditions, their families […] Article Reflections on how COVID has changed the health landscape Reflections on how COVID has changed the health landscape and highlighted the importance of supported self-management By Ailsa Bosworth, MBE As we begin 2022, I’ve taken time out to reflect on what has happened in healthcare delivery generally, but especially within rheumatology, and many of you will be aware that we have produced resources to […] Load more ↓ Help support others Because of your generous donations NRAS will continue to be there for everyone affected by RA. MonthlySinglePay in Funds £3£8£15Other £18.74£41.44£165.75Other £50£100£500Other Donate now!
01. How NRAS supports research From conducting our own research about the impact of RA on people’s lives to assisting third-party researchers, academics and professionals – we support research in a number of ways. Read more
03. Get involved in research NRAS is committed to improving a broad range of outcomes for the RA community. In achieving these aims we work on a number of separate but entwined strategies covering issues such as policy reform, the develop of self-management resources, providing support and help to people experiencing health, social and psychological issues related to their RA. Take part
04. Research outcomes It is important that the full loop occurs when it comes to research, its not just taking part it is also finding out the results. Within this section you will find research outcomes. Read more
05. For researchers NRAS is open to supporting a wide variety of institutions and commercial organisations with their research via various means of recruitment, focus groups, promotion of research and production of surveys. Read more
What's Happening News, 13 May Update on COVID-19 Vaccine All patients with RA are encouraged to receive a COVID-19 vaccine. This includes people taking Disease Modifying Anti Rhematic Drugs such as methotrexate, sulfasalazine, leflunomide and hydroxychloroquine and/or advanced therapies such as biologics, biosimilars and JAK inhibitors. The only potential exception is for those on rituximab for which it is recommended to have a consultation […] News, 21 Sep Covid Choices survey results 1 in 3 people delay medical care in COVID-19 pandemic. Lack of information drives on-going fear of attending appointments. Patients need clear, consistent information about COVID-19 safety measures before going to hospital and GP appointments, according to a public survey led by the Patient Information Forum (PIF). 21/09/2020 More than 800 people responded to the […] Get all the latest news and events straight to your inbox with our regular email. Don't worry, we won't send you spam! Sign up
News, 13 May Update on COVID-19 Vaccine All patients with RA are encouraged to receive a COVID-19 vaccine. This includes people taking Disease Modifying Anti Rhematic Drugs such as methotrexate, sulfasalazine, leflunomide and hydroxychloroquine and/or advanced therapies such as biologics, biosimilars and JAK inhibitors. The only potential exception is for those on rituximab for which it is recommended to have a consultation […]
News, 21 Sep Covid Choices survey results 1 in 3 people delay medical care in COVID-19 pandemic. Lack of information drives on-going fear of attending appointments. Patients need clear, consistent information about COVID-19 safety measures before going to hospital and GP appointments, according to a public survey led by the Patient Information Forum (PIF). 21/09/2020 More than 800 people responded to the […]
Search for resources Try searching our resource hub to find the articles, videos, tools and publications most helpful for you. I am… Employer Health Professional Someone with RASelect topic… About NRAS COVID-19 Diagnosis and Monitoring Diet and Exercise Family Planning Healthcare professionals Other Conditions RA Stories Research Self Care Symptoms and Causes Treatment Work and BenefitsSelect resource type… Article Publication Video Clear All Article MoNoPly study Are you living with painful inflammatory arthritis and interested in taking part in a research study? This MoNoPly study aims to understand what aspects of brain function might be contributing to pain symptoms in people with chronic pain. This project is looking for people who: Are aged 18+. Experience pain from inflammatory arthritis (e.g. rheumatoid […] Article FAQs on New Antiviral Treatment Who is eligible for the treatment? The official list of those eligible can be found in appendix 1 of the clinical commissioning policy published on the 24th of December 2021. See the full, published policy here. With regards to rheumatoid arthritis and immune-mediated inflammatory disorders, the following have been identified: IMID treated with rituximab or other […] Article Research Priorities in Psoriatic Arthritis Introduction This process aimed to identify and prioritise the Top 10 research questions or evidence uncertainties for psoriatic arthritis in adults. A Priority Setting Partnership aims to help ensure that those who fund health research know what really matters to people living with psoriatic arthritis, their carers and clinicians. Methods The British Psoriatic Arthritis Consortium […] Article Office Admin Assistant The National Rheumatoid Arthritis Society (NRAS), is the only patient-led organisation in the UK specialising in rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). Due to its targeted focus on RA and JIA, NRAS provides truly expert and wide-ranging services to support, educate and campaign for people living with these complex autoimmune conditions, their families […] Article Reflections on how COVID has changed the health landscape Reflections on how COVID has changed the health landscape and highlighted the importance of supported self-management By Ailsa Bosworth, MBE As we begin 2022, I’ve taken time out to reflect on what has happened in healthcare delivery generally, but especially within rheumatology, and many of you will be aware that we have produced resources to […] Load more ↓
Article MoNoPly study Are you living with painful inflammatory arthritis and interested in taking part in a research study? This MoNoPly study aims to understand what aspects of brain function might be contributing to pain symptoms in people with chronic pain. This project is looking for people who: Are aged 18+. Experience pain from inflammatory arthritis (e.g. rheumatoid […]
Article FAQs on New Antiviral Treatment Who is eligible for the treatment? The official list of those eligible can be found in appendix 1 of the clinical commissioning policy published on the 24th of December 2021. See the full, published policy here. With regards to rheumatoid arthritis and immune-mediated inflammatory disorders, the following have been identified: IMID treated with rituximab or other […]
Article Research Priorities in Psoriatic Arthritis Introduction This process aimed to identify and prioritise the Top 10 research questions or evidence uncertainties for psoriatic arthritis in adults. A Priority Setting Partnership aims to help ensure that those who fund health research know what really matters to people living with psoriatic arthritis, their carers and clinicians. Methods The British Psoriatic Arthritis Consortium […]
Article Office Admin Assistant The National Rheumatoid Arthritis Society (NRAS), is the only patient-led organisation in the UK specialising in rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). Due to its targeted focus on RA and JIA, NRAS provides truly expert and wide-ranging services to support, educate and campaign for people living with these complex autoimmune conditions, their families […]
Article Reflections on how COVID has changed the health landscape Reflections on how COVID has changed the health landscape and highlighted the importance of supported self-management By Ailsa Bosworth, MBE As we begin 2022, I’ve taken time out to reflect on what has happened in healthcare delivery generally, but especially within rheumatology, and many of you will be aware that we have produced resources to […]
Help support others Because of your generous donations NRAS will continue to be there for everyone affected by RA. MonthlySinglePay in Funds £3£8£15Other £18.74£41.44£165.75Other £50£100£500Other Donate now!